Given how effectively the immune system can eliminate foreign threats such bacteria and viruses, hopes are high for the development of strategies that might turn these same defense mechanisms against cancerous targets.
However, attempts to train the immune system to recognize malignancies via the intravenous injection of vaccines that present tumor-derived antigens have fallen short.
According to Kenichi Asano, a researcher with Masato Tanaka’s group at the RIKEN Center for Allergy and Immunology in Yokohama, this is the result of ‘tolerance’ mechanisms that protect against autoimmune disease. “Billions of cells die every day, and cell corpses must be removed swiftly from our body in order not to induce detrimental effects,” he says. In this scenario, macrophage cells in the spleen clean house by devouring such debris in a process known as phagocytosis, thereby preventing dead cells from triggering an inflammatory response.
Tumor cells delivered into the lymphatic system via subcutaneous injection, however, can successfully elicit a strong immune response, and new research from Asano and colleagues explains why this is the case. In order to rouse an effective reaction, phagocytic cells must present recognizable chunks of those dead cells to tumor-killing cytotoxic T lymphocytes (CTLs). The researchers identified a very specific subset of macrophages within the lymph nodes that perform this task.
Intriguingly, these cells, which are distinguishable by their expression of the cell-surface protein CD169, are non-migratory and reside stably within the sinuses of the lymph node, awaiting their prey like spiders in a web. Dead cancer cells delivered to these sinuses via the lymphatic system are rapidly digested by the macrophages (Fig. 1), which in turn cross-present the resulting antigens to CTLs. By selectively killing off these macrophages with diphtheria toxin, the researchers were able to essentially disable the immune response. “Without CD169 macrophages, tumor-directed T cells were no longer activated—that means these cells dominate anti-tumor immunity after tumor cell death,” says Asano.
These findings help explain why the dead cells that slough off of tumors into the lymphatic system during radiation or chemotherapy are sometimes sufficient to provoke an immune response, and could provide the foundation for far more effective cancer immunotherapy strategies. “I believe it is very promising to mount anti-tumor immunity in patients with solid tumors by delivering tumor antigens specifically to CD169 macrophages,” says Asano. “It's my dream to invent artificial materials that possess the characteristics of dead cells and are safe for administration to patients.”
The corresponding author for this highlight is based at the Laboratory for Innate Cellular Immunity, RIKEN Research Center for Allergy and Immunology
 Asano, K., Nabeyama, A., Miyake, Y., Qiu, C.-H., Kurita, A., Tomura, M., Kanagawa, O., Fujii, S.-I. & Tanaka, M. CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens. Immunity 34, 85–95 (2011).
gro-pr | Research asia research news
Staying in Shape
16.08.2018 | Max-Planck-Institut für molekulare Zellbiologie und Genetik
Chips, light and coding moves the front line in beating bacteria
16.08.2018 | Okinawa Institute of Science and Technology (OIST) Graduate University
Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...
Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.
When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...
Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.
Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....
Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.
Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...
Scientists have discovered that the electrical resistance of a copper-oxide compound depends on the magnetic field in a very unusual way -- a finding that could help direct the search for materials that can perfectly conduct electricity at room temperatur
What happens when really powerful magnets--capable of producing magnetic fields nearly two million times stronger than Earth's--are applied to materials that...
08.08.2018 | Event News
27.07.2018 | Event News
25.07.2018 | Event News
16.08.2018 | Life Sciences
16.08.2018 | Earth Sciences
16.08.2018 | Life Sciences